All lobbying filings

HIMS & HERS HEALTH, INC.

Lobbying for HIMS & HERS HEALTH, INC. · Telehealth services

Filing 3rd Quarter - Amendment

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $330,000.00 expenses · posted Jan 23, 2026

Official filing document

Bills named in this filing 5

HR 5316
Drug Shortage Compounding Patient Access Act of 2025
HR 4605
End Prescription Drug Ads Now Act
HR 238
Healthy Technology Act of 2025
S 2068
End Prescription Drug Ads Now Act
S 5040
Protecting Patients from Deceptive Drug Ads Online Act

Lobbying activity 1

Health Issues

Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.